series-c-plus
Stage
3
Investors
About
DBV Technologies is a clinical-stage biopharmaceutical company focused on developing non-invasive immunotherapy treatments for food allergies using its proprietary Viaskin patch technology.
Explore DBV Technologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.